Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Galenpharma Brand of Buserelin Acetate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 600,469Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 Bachem AG
    Switzerland
    		 Bachem AG 225MF10159 Buserelin 2013-08-14 2013-08-14 Hauptstrasse 144,4416 Bubendorf Switzerland
    26/09/2024 BCN Peptides
    Spain
    		 BCN Peptides S. A. 305MF10126 Buserelin 2023-11-29 2023-11-29 Poligono industrial Els Vinyets-Els Fogars. Sector II 08777-Sant Quinti de Mediona, Barcelona, ​​Spain